Levodopa/Dopamine Analogs as Inhibitors of DNA Synthesis in Human Melanoma Cells.
- 1 May 1989
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 92 (s5) , 329S-331S
- https://doi.org/10.1111/1523-1747.ep13076753
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Sequential inhibitory effects of antitumor agents related to levodopa and dopamine upon DNA synthetic enzymesBiochemical Pharmacology, 1986
- Potentiation by α-difluoromethylornithine of the activity of 3,4-dihydroxybenzylamine, a tyrosinase-dependent melanolytic agent, against B16 melanomaBiochemical Pharmacology, 1985
- Inhibition of ribonucleotide reductase by antitumor agents related to levodopa and dopamineBiochemical Pharmacology, 1985
- Inhibitor evidence for allosteric interaction in the replitase multienzyme complexNature, 1983
- 3,4-Dihydroxybenzylamine: An Improved Dopamine Analog Cytotoxic for Melanoma Cells in Part Through Oxidation Products Inhibitory to DNA PolymeraseJournal of Investigative Dermatology, 1983
- Regulation of ribonucleotide reductase in mammalian cells by chemotherapeutic agentsAdvances in Enzyme Regulation, 1981
- AnnouncementJournal of Investigative Dermatology, 1978